Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-08-23 08:54:41 - browse：186

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： How doctors and nurses shape Google's AI

WSS

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Female surgeons have lower rates of long

Resistance to opioid

Tome Biosciences co

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Latigo launches with $135 million for Vertex

entertainment

Wikipedia

Wikipedia

Peter Hotez and the public health issue of online harassment

A revolution in caring for preterm infants

Duchenne breakthrough therapy leaves behind pioneering families

Cancer cells are shown to suck energy source from immune cells

Medical leaders decry Supreme Court decision on affirmative action

Latigo launches with $135 million for Vertex

Alkermes shareholders re

Akero's treatment for NASH falls short in cirrhosis study

Moonlake's readout produced a cash windfall. Risks remain

How doctors and nurses shape Google's AI

hotspot

Congress considering partial increase for doctor pay in Medicare

What the Wegovy shortage looks like for doctors — and for patients

STAT Boddities: What happens to the brain when we get scared?

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Why don't Americans have at

Eli Lilly reports tirzepatide MASH success during Q4 earnings

hotspot

knowledge

Wikipedia

hotspot